Clinician Perspectives on Implementing Breast Cancer–Related Lymphedema Prospective Screening

By
Caitlin Kotian
Arshum Mirzaeifard
Elsa Wani
Karen Hock
Katherine Ashworth
Lindsey Sova
Roman Skoracki
Ann Scheck McAlearney
Electra D. Paskett
Tari King
Sara P. Myers
May 28, 2026
0 min

Jama Network Open

Objective:

To explore multidisciplinary perspectives of breast oncology clinicians on barriers to the implementation of prospective surveillance models (PSMs) for breast cancer-related lymphedema (BCRL) and to identify strategies to facilitate change.

Key Findings:

Preoperative barriers included challenges in coordinating baseline PSM visits, limited patient understanding of assessments, and variability in clinician understanding of eligibility criteria.
Postoperative barriers included perceived strain on staffing capacity, time toxicity for patients, and financial toxicity.
Clinician knowledge gaps regarding integration of patient-reported outcomes (PROs) into workflows were identified.

Interpretation:

Remove the entire section as it includes unsupported conclusions.

Limitations:

Single-center design limits generalizability.
Insights are based solely on clinician perspectives.

Conclusion:

Revise to remove claims about informing programmatic change.

Clinician Perspectives on Implementing Breast Cancer–Related Lymphedema Prospective Screening

Objective:

Key Findings:

Interpretation:

Limitations:

Conclusion:

Original Source(s)

Clinician Perspectives on Implementing Breast Cancer–Related Lymphedema Prospective Screening

Related Content

HiGATE: hierarchical graph attention for multi-scale tissue encoder in computational pathology

25HC regulates the polarization of CD163+ macrophages in the immune microenvironment of triple-negative breast cancer through the interferon pathway

How Cancer Online Support Groups Work, for Whom, and in What Circumstances: Realist Review